At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...
It’s been long known that women with BRCA1 and BRCA2 gene mutations are at higher risk for breast and ovarian cancer. More ...
Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.
Groundbreaking research presented at the San Antonio Breast Cancer Symposium suggests thousands of women with early-stage ...
Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of ...
Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...
A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests.
Over half of breast cancer survivors (57.2%) report oncologist-led care more than 5 years posttreatment, while only 22.4% ...
This week, the Henry B. Gonzalez Convention Center is where leading doctors from all over have gathered to share research and ...
The Barbara Cares Foundation, a Fort Worth-based nonprofit, has $10,000 of funding to give out by the end of the year.